Notably, TPP+ conjugates such as 3-carboxy-proxyl nitroxide (Mito-CP) and Metformin (Mito-Met10) have been shown to directly activate ULK1 [501], a key initiator of mitophagy, thereby promoting an anti-tumor mitophagy response. This evidence concerns the gene ULK1 and neoplasm.